公司資料
Galera Therapeutics 股價、新聞與催化劑
- 股票代碼:
- GRTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
17.60 USD (-2.22%)
收盤價
最後更新: 2026年7月10日
—
市值
股價為何變動
Current closing-price context is not available for GRTX.
公司概覽
業務概覽
Galera Therapeutics was a biotech company focused on oncology supportive care and radiation-related therapies before its restructuring and decline. Its legacy was centered on protecting patients during cancer treatment.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Galera sat in specialty oncology biotechnology.
商業模式特徵
The business depended on clinical development, regulatory steps, and the challenge of translating supportive-care science into a durable franchise.
生技產業定位
Galera belongs to the historical oncology-biotech group rather than the current live public-company set.
未來催化劑
- Galera is now largely a legacy and closeout story, so the catalysts are corporate resolution rather than a fresh pipeline readout. The market is focused on what value remains after the prior oncology effort.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。